Showing results (151-160 of 212) with videos related to
Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed plateletsBianca Rocca, Paola Secchiero, Giovanni Ciabattoni, et al.Biomed Research International|April 18, 2018
Novel Compliant Scaffold with Specific Design for Venous System: Results of a Porcine Model StudyPierfrancesco Veroux, Alessia Giaquinta, Carla Virgilio, et al.Oncotarget|June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.Clinical Biochemistry|May 29, 2017
Association between thyroid hormones and TRAILStella Bernardi, Fleur Bossi, Barbara Toffoli, et al.Journal of Medicinal Chemistry|December 15, 2015
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic ActivityClaudio Trapella, Rebecca Voltan, Elisabetta Melloni, et al.Blood|June 19, 2004
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicityPrisco Mirandola, Cristina Ponti, Giuliana Gobbi, et al.International Journal of Molecular Sciences|August 10, 2024
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut MicrobiotaPaola Secchiero, Erika Rimondi, Annalisa Marcuzzi, et al.Journal of Neuroimmunology|January 10, 2021
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patientsNicole Ziliotto, Nicola Lamberti, Fabio Manfredini, et al.Oncotarget|September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemiaRebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.Clinical Science (London, England : 1979)|May 18, 2019
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?Stella Bernardi, Rebecca Voltan, Erika Rimondi, et al.Pageof 22